Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography
NCT01683825
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
23
Enrollment
OTHER
Sponsor class
Conditions
Cardiac Amyloidosis
Interventions
DRUG:
F-18 florbetapir PET
Sponsor
Brigham and Women's Hospital